Integra LifeSciences Holdings Quick Ratio 2010-2025 | IART
Historical quick ratio values for Integra LifeSciences Holdings (IART) over the last 10 years.
| Integra LifeSciences Holdings Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-06-30 | $0.68B | $0.93B | 0.73 |
| 2025-03-31 | $0.66B | $0.92B | 0.72 |
| 2024-12-31 | $0.65B | $0.92B | 0.71 |
| 2024-09-30 | $0.66B | $0.91B | 0.73 |
| 2024-06-30 | $0.69B | $0.33B | 2.10 |
| 2024-03-31 | $1.01B | $0.30B | 3.35 |
| 2023-12-31 | $0.67B | $0.31B | 2.18 |
| 2023-09-30 | $0.66B | $0.36B | 1.86 |
| 2023-06-30 | $0.70B | $0.38B | 1.85 |
| 2023-03-31 | $0.68B | $0.28B | 2.40 |
| 2022-12-31 | $0.84B | $0.32B | 2.61 |
| 2022-09-30 | $0.89B | $0.30B | 2.91 |
| 2022-06-30 | $0.82B | $0.30B | 2.77 |
| 2022-03-31 | $0.74B | $0.32B | 2.34 |
| 2021-12-31 | $0.84B | $0.34B | 2.46 |
| 2021-09-30 | $0.78B | $0.33B | 2.33 |
| 2021-06-30 | $0.71B | $0.32B | 2.22 |
| 2021-03-31 | $0.71B | $0.41B | 1.73 |
| 2020-12-31 | $0.93B | $0.40B | 2.31 |
| 2020-09-30 | $0.84B | $0.26B | 3.31 |
| 2020-06-30 | $0.61B | $0.21B | 2.86 |
| 2020-03-31 | $0.67B | $0.25B | 2.72 |
| 2019-12-31 | $0.54B | $0.33B | 1.64 |
| 2019-09-30 | $0.58B | $0.30B | 1.92 |
| 2019-06-30 | $0.57B | $0.32B | 1.82 |
| 2019-03-31 | $0.54B | $0.29B | 1.86 |
| 2018-12-31 | $0.50B | $0.26B | 1.88 |
| 2018-09-30 | $0.54B | $0.26B | 2.08 |
| 2018-06-30 | $0.53B | $0.23B | 2.28 |
| 2018-03-31 | $0.56B | $0.34B | 1.66 |
| 2017-12-31 | $0.53B | $0.35B | 1.51 |
| 2017-09-30 | $0.71B | $0.21B | 3.39 |
| 2017-06-30 | $0.38B | $0.18B | 2.15 |
| 2017-03-31 | $0.33B | $0.19B | 1.75 |
| 2016-12-31 | $0.28B | $0.12B | 2.25 |
| 2016-09-30 | $0.29B | $0.16B | 1.81 |
| 2016-06-30 | $0.27B | $0.15B | 1.83 |
| 2016-03-31 | $0.27B | $0.16B | 1.74 |
| 2015-12-31 | $0.23B | $0.14B | 1.63 |
| 2015-09-30 | $0.29B | $0.14B | 2.08 |
| 2015-06-30 | $0.37B | $0.16B | 2.35 |
| 2015-03-31 | $0.29B | $0.13B | 2.28 |
| 2014-12-31 | $0.34B | $0.13B | 2.70 |
| 2014-09-30 | $0.33B | $0.13B | 2.55 |
| 2014-06-30 | $0.34B | $0.13B | 2.68 |
| 2014-03-31 | $0.33B | $0.12B | 2.78 |
| 2013-12-31 | $0.31B | $0.12B | 2.63 |
| 2013-09-30 | $0.30B | $0.12B | 2.48 |
| 2013-06-30 | $0.28B | $0.11B | 2.58 |
| 2013-03-31 | $0.27B | $0.11B | 2.53 |
| 2012-12-31 | $0.28B | $0.11B | 2.63 |
| 2012-09-30 | $0.32B | $0.11B | 2.88 |
| 2012-06-30 | $0.31B | $0.11B | 2.72 |
| 2012-03-31 | $0.29B | $0.11B | 2.75 |
| 2011-12-31 | $0.28B | $0.10B | 2.76 |
| 2011-09-30 | $0.30B | $0.10B | 2.82 |
| 2011-06-30 | $0.32B | $0.12B | 2.72 |
| 2011-03-31 | $0.27B | $0.16B | 1.66 |
| 2010-12-31 | $0.30B | $0.20B | 1.48 |
| 2010-09-30 | $0.24B | $0.10B | 2.32 |
| 2010-06-30 | $0.24B | $0.09B | 2.85 |
| 2010-03-31 | $0.23B | $0.16B | 1.45 |
| 2009-12-31 | $0.23B | $0.16B | 1.44 |
| 2009-09-30 | $0.26B | $0.22B | 1.19 |
| 2009-06-30 | $0.28B | $0.22B | 1.31 |
| 2009-03-31 | $0.34B | $0.17B | 1.97 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.111B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.846B | 22.60 |
| Intuitive Surgical (ISRG) | United States | $172.230B | 71.39 |
| IDEXX Laboratories (IDXX) | United States | $51.191B | 53.28 |
| Edwards Lifesciences (EW) | United States | $47.784B | 31.67 |
| Alcon (ALC) | Switzerland | $39.973B | 26.83 |
| IQVIA Holdings (IQV) | United States | $32.647B | 18.45 |
| DexCom (DXCM) | United States | $32.027B | 48.04 |
| Mettler-Toledo (MTD) | United States | $27.126B | 32.20 |
| STERIS (STE) | Ireland | $24.578B | 26.16 |
| Waters (WAT) | United States | $17.663B | 24.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.277B | 0.00 |
| Hologic (HOLX) | United States | $15.294B | 16.57 |
| Penumbra (PEN) | United States | $9.973B | 72.86 |
| Sysmex ADR (SSMXY) | Japan | $8.372B | 26.60 |
| Globus Medical (GMED) | United States | $8.202B | 18.92 |
| Masimo (MASI) | United States | $7.912B | 26.63 |
| Teleflex (TFX) | United States | $5.553B | 8.96 |
| Glaukos (GKOS) | United States | $5.215B | 0.00 |
| TransMedics (TMDX) | United States | $4.155B | 63.15 |
| Integer Holdings (ITGR) | United States | $3.759B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.915B | 16.68 |
| Alphatec Holdings (ATEC) | United States | $2.351B | 0.00 |
| Veracyte (VCYT) | United States | $2.320B | 32.05 |
| PROCEPT BioRobotics (PRCT) | United States | $2.191B | 0.00 |
| Artivion (AORT) | United States | $2.030B | 102.43 |
| Nihon Kohden (NHNKY) | Japan | $1.894B | 22.61 |
| Elekta AB (EKTAY) | Sweden | $1.854B | 17.34 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.073B | 0.00 |
| IRadimed (IRMD) | United States | $0.888B | 43.10 |
| Tandem Diabetes Care (TNDM) | United States | $0.722B | 0.00 |
| AxoGen (AXGN) | United States | $0.716B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.665B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.574B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 9.31 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.462B | 3.71 |
| Treace Medical Concepts (TMCI) | United States | $0.451B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 86.08 |
| RxSight (RXST) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.286B | 19.72 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.234B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.112B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.109B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.073B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 23.33 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.027B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.33 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |